Clinical Trial Update: Assessing the Clinical Outcomes of Dapagliflozin Versus Acetazolamide in Patients With Acute Heart Failure [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update outlines a Phase 2/Phase 3 study comparing dapagliflozin to acetazolamide in patients with acute heart failure, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Diamox (acetazolamide)
• FARXIGA (dapagliflozin)

Snippet

Sponsor: Mansoura University | Conditions: Acute Heart Failure | Phase 2, Phase 3 | Status: RECRUITING